186 related articles for article (PubMed ID: 29194436)
21. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.
Hall ED; Oostveen JA; Gurney ME
Glia; 1998 Jul; 23(3):249-56. PubMed ID: 9633809
[TBL] [Abstract][Full Text] [Related]
22. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
23. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
24. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis.
Ekhtiari Bidhendi E; Bergh J; Zetterström P; Forsberg K; Pakkenberg B; Andersen PM; Marklund SL; Brännström T
Acta Neuropathol; 2018 Dec; 136(6):939-953. PubMed ID: 30284034
[TBL] [Abstract][Full Text] [Related]
25. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease.
Mourelatos Z; Gonatas NK; Stieber A; Gurney ME; Dal Canto MC
Proc Natl Acad Sci U S A; 1996 May; 93(11):5472-7. PubMed ID: 8643599
[TBL] [Abstract][Full Text] [Related]
26. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
[TBL] [Abstract][Full Text] [Related]
27. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis.
Schütz B
Neurobiol Dis; 2005 Oct; 20(1):131-40. PubMed ID: 16137574
[TBL] [Abstract][Full Text] [Related]
28. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
29. DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS.
Lev N; Barhum Y; Lotan I; Steiner I; Offen D
PLoS One; 2015; 10(3):e0117190. PubMed ID: 25822630
[TBL] [Abstract][Full Text] [Related]
30. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
Ng SK; Higashimori H; Tolman M; Yang Y
Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
[TBL] [Abstract][Full Text] [Related]
31. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
[TBL] [Abstract][Full Text] [Related]
32. The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS).
Paul P; de Belleroche J
Front Synaptic Neurosci; 2014; 6():10. PubMed ID: 24795623
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
34. Kif1Bbeta isoform is enriched in motor neurons but does not change in a mouse model of amyotrophic lateral sclerosis.
Conforti L; Dell'Agnello C; Calvaresi N; Tortarolo M; Giorgini A; Coleman MP; Bendotti C
J Neurosci Res; 2003 Mar; 71(5):732-9. PubMed ID: 12584731
[TBL] [Abstract][Full Text] [Related]
35. Human motor neurons generated from neural stem cells delay clinical onset and prolong life in ALS mouse model.
Lee HJ; Kim KS; Ahn J; Bae HM; Lim I; Kim SU
PLoS One; 2014; 9(5):e97518. PubMed ID: 24844281
[TBL] [Abstract][Full Text] [Related]
36. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.
Wang L; Gutmann DH; Roos RP
Hum Mol Genet; 2011 Jan; 20(2):286-93. PubMed ID: 20962037
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1
Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD
CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
[TBL] [Abstract][Full Text] [Related]
38. Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosis.
Peters OM; Millership S; Shelkovnikova TA; Soto I; Keeling L; Hann A; Marsh-Armstrong N; Buchman VL; Ninkina N
Neurobiol Dis; 2012 Oct; 48(1):124-31. PubMed ID: 22750530
[TBL] [Abstract][Full Text] [Related]
39. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.
Sironi F; Vallarola A; Violatto MB; Talamini L; Freschi M; De Gioia R; Capelli C; Agostini A; Moscatelli D; Tortarolo M; Bigini P; Introna M; Bendotti C
Stem Cell Res; 2017 Dec; 25():166-178. PubMed ID: 29154076
[TBL] [Abstract][Full Text] [Related]
40. Altered macroautophagy in the spinal cord of SOD1 mutant mice.
Li L; Zhang X; Le W
Autophagy; 2008 Apr; 4(3):290-3. PubMed ID: 18196963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]